Echo Therapeutics, Inc. 4
4 · Echo Therapeutics, Inc. · Filed Oct 2, 2013
Insider Transaction Report
Form 4
ENRIGHT VINCENT D
Director
Transactions
- Award
Nonqualified Stock Option (right to buy)
2013-10-01+1,500→ 14,500 totalExercise: $2.76From: 2014-10-01Exp: 2023-10-01→ Common Stock (1,500 underlying) - Award
Common Stock
2013-10-01+400→ 13,700 total
Footnotes (2)
- [F1]The shares vest on October 1, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of or substantially all of the assets of the Company of all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As uses herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred and eighty (180) days; or (d) or a combination of cash and the foregoing securities.
- [F2]The Options vest on October 1, 2014; provided, however, that all unvested Options shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds.